Structures of CYLD USP with Met1-or Lys63-linked diubiquitin reveal mechanisms for dual specificity

Nature Structural and Molecular Biology

Volumn 22, Issue 3, 2015, Pages 222-229

  Sato, Yusuke ^a   Goto, Eiji ^b   Shibata, Yuri ^a   Kubota, Yuji ^c   Yamagata, Atsushi ^a   Goto Ito, Sakurako ^a   Kubota, Keiko ^a   Inoue, J I ^a   Takekawa, Mutsuhiro ^c   Tokunaga, Fuminori ^b   Fukai, Shuya ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; DEUBIQUITINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; METHIONINE; SERINE; UBIQUITIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN; ZEBRAFISH PROTEIN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROGEN BOND; LUCIFERASE ASSAY; MOLECULAR RECOGNITION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; ZEBRA FISH; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; HEK293 CELL LINE; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

DANIO RERIO;

BINDING SITES; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HEK293 CELLS; HUMANS; KINETICS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UBIQUITIN-SPECIFIC PROTEASES; ZEBRAFISH PROTEINS;

EID: 84924269252     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2970     Document Type: Article

References (37)

1. Blake, P.W. & Toro, J.R. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum. Mutat. 30, 1025-1036 (2009
2. van den Ouweland, A.M., et al. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Fam. Cancer 10, 127-132 (2011
3. Bignell, G.R., et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160-165 (2000
4. Trompouki, E., et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-?B activation by TNFR family members. Nature 424, 793-796 (2003
5. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-?B. Nature 424, 797-801 (2003
6. Kovalenko, A., et al. The tumour suppressor CYLD negatively regulates NF-?B signalling by deubiquitination. Nature 424, 801-805 (2003
7. Nijman, S.M., et al A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786 (2005
8. Komander, D., et al. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol. Cell 29, 451-464 (2008
9. Komander, D., et al. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466-473 (2009
10. Virdee, S., Ye, Y., Nguyen, D.P., Komander, D. & Chin, J.W. Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nat. Chem. Biol. 6, 750-757 (2010
11. Bremm, A., Freund, S.M. & Komander, D. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 17, 939-947 (2010
12. Ye, Y., et al. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 12, 350-357 (2011
13. Trang, V.H., et al. Nonenzymatic polymerization of ubiquitin: single-step synthesis and isolation of discrete ubiquitin oligomers. Angew. Chem. Int. Edn Engl. 51, 13085-13088 (2012
14. Hayden, M.S. & Ghosh, S. NF-?B, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203-234 (2012
15. Iwai, K. Diverse ubiquitin signaling in NF-?B activation. Trends Cell Biol. 22, 355-364 (2012
16. Glickman, M.H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428 (2002
17. Wang, C., et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001
18. Adhikari, A., Xu, M. & Chen, Z.J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26, 3214-3226 (2007
19. Tokunaga, F., et al. Involvement of linear polyubiquitylation of NEMO in NF-?B activation. Nat. Cell Biol. 11, 123-132 (2009
20. Rahighi, S., et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-?B activation. Cell 136, 1098-1109 (2009
21. Sato, Y., et al. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc. Natl. Acad. Sci. USA 108, 20520-20525 (2011
22. Tokunaga, F., et al. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-?B regulation. EMBO J. 31, 3856-3870 (2012
23. Hu, M., et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054 (2002
24. Almeida, S., Maillard, C., Itin, P., Hohl, D. & Huber, M. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J. Invest. Dermatol. 128, 587-593 (2008
25. Takiuchi, T., et al. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 19, 254-272 (2014
26. Renatus, M., et al. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure 14, 1293-1302 (2006
27. Krissinel, E. & Henrick, K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256-2268 (2004
28. Sato, Y., et al. Structural basis for specific cleavage of Lys63-linked polyubiquitin chains. Nature 455, 358-362 (2008
29. Juang, Y.C., et al. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol. Cell 45, 384-397 (2012
30. Wiener, R., Zhang, X., Wang, T. & Wolberger, C. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 483, 618-622 (2012
31. Licchesi, J.D., et al. An ankyrin-repeat ubiquitin-binding domain determines TRABIDs specificity for atypical ubiquitin chains. Nat. Struct. Mol. Biol. 19, 62-71 (2012
32. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997
33. Collaborative Computational Project, Number 4. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994
34. Vagin, A. & Teplyakov, A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022-1025 (1997
35. Vijay-Kumar, S., Bugg, C.E. & Cook, W.J. Structure of ubiquitin refined at 1.8 Aresolution. J. Mol. Biol. 194, 531-544 (1987
36. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004
37. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997